|
⚲
|
| Keyboard |
| Deer Management Co LLC
✚
|
|
|---|---|
| CRD # | 159279 |
| SEC # | 801-125875 |
| CIK # | 0001494127 |
| AUM | 20.24 B (2026-05-13) |
| Employees | 191 (43% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 914-833-5300 |
| Address | 1865 Palmer Avenue Larchmont, NY 10538 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Servicetitan Inc | 0.3 | ||
| Stubhub Holdings Inc | 0.1 | ||
| Hinge Health Inc | 0.1 | ||
| CS Disco Inc | 0.0 | ||
| Kymera Therapeutics Inc | 0.0 | ||
| Navsight Holdings Inc | 0.0 | ||
| Fiverr International Ltd | 0.0 | ||
| Fractyl Health Inc | 0.0 | ||
| TScan Therapeutics Inc | 0.0 | ||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Bessemer Venture Partners an I LP | 2026-03-30 | 83.3 M | |
| VC | Bessemer Venture Partners India II Institutional LP | [2026-03-30] | 291.8 M | |
| Filed 2025-03-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Bessemer Venture Partners India II LP | 2026-03-30 | 61.3 M | |
| PE | Gator Co-Invest BE LP | [2026-03-30] | 45.2 M | |
| Filed 2025-07-11 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest Li LP | [2026-03-30] | 70.9 M | |
| Filed 2025-10-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest TE LP | [2026-03-30] | 42.5 M | 42.7 M |
| Filed 2025-07-14 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest VE LP | [2026-03-30] | 53.8 M | |
| Filed 2025-06-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest PA LP | [2024-03-29] | 32.1 M | |
| Filed 2023-08-01 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Bessemer Venture Partners XII Advisors & Influencers LP | [2023-03-31] | 48.4 M | |
| Filed 2022-06-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Bessemer Venture Partners XII Institutional LP | [2023-03-31] | 3,238.4 M | |
| Filed 2022-06-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 36 | 20.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 36 | 20.2 |
| By Discretionary | ||
| Discretionary | 36 | 20.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 36 | 20.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 18.5 | |
| United States Persons | 1.7 | |
| Total | 36 | 20.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Adam Fisher | Director | 42 | 7 | |
| Robert Goodman | Director, Executive Officer | 95 | 4 | |
| David Cowan | Director | 55 | 3 | |
| Brian Feinstein | Director, Executive Officer | 38 | 3 | |
| Robert Stavis | Director | 24 | 3 | |
| Ethan Kurzweil | Director | 23 | 3 | |
| Richard Bennett | Director | 20 | 3 | |
| Byron Deeter | Director | 70 | 2 | |
| Jeremy Levine | Director, Executive Officer | 64 | 2 | |
| Stephen Kraus | Director | 45 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001494127] | |
| 3 | [0001494127] | |
| 4 | [0001494127] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tempest Therapeutics Inc OVAS
Stock Option (right to buy) · derivative
|
2014-06-13 | Grant | 6,500 | $0.00 | |
|
Tempest Therapeutics Inc OVAS
Stock Option (right to buy) · derivative
|
2013-06-07 | Grant | 4,448 | $0.00 | |
|
Eloqua Inc ELOQ
Common Stock
|
2013-02-08 | Disposed to issuer | 5,163,934 | ||
|
Tempest Therapeutics Inc NONE
Common Stock
|
2012-08-13 | Conversion | 909,090 | $0.00 | |
|
Tempest Therapeutics Inc NONE
Series A Preferred Stock · derivative
|
2012-08-13 | Conversion | 3,000,000 | $0.00 | |
|
Tempest Therapeutics Inc NONE
Series B Preferred Stock · derivative
|
2012-08-13 | Conversion | 909,090 | $0.00 | |
|
Tempest Therapeutics Inc NONE
Common Stock
|
2012-08-13 | Conversion | 1,482,944 | $0.00 | |
|
Eloqua Inc ELOQ
Series C Preferred Stock · derivative
|
2012-08-07 | Conversion | 5,163,934 | $0.00 | |
|
Eloqua Inc ELOQ
Common Stock
|
2012-08-07 | Conversion | 5,163,934 | ||
|
Verastem Inc VSTM
Stock Option (Right to Buy) · derivative
|
2012-03-06 | Grant | 12,500 | $0.00 | |
|
Verastem Inc VSTM
Series C Preferred Stock · derivative
|
2012-02-01 | Conversion | 133,333 | $0.00 | |
|
Verastem Inc VSTM
Series A Preferred Stock · derivative
|
2012-02-01 | Conversion | 4,000,000 | $0.00 | |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Conversion | 714,285 | $0.00 | |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Buy | 100,000 | $10.00 | 1,000,000 |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Conversion | 38,095 | $0.00 | |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Conversion | 1,142,857 | $0.00 | |
|
Verastem Inc VSTM
Series B Preferred Stock · derivative
|
2012-02-01 | Conversion | 2,500,000 | $0.00 |
| Comparable Firms | State | AUM |
|---|---|---|
|
THL Managers VII LLC
✚
|
MA | 21.48 B |
|
Charlesbank Capital Partners LLC
✚
|
MA | 21.06 B |
|
Madison Dearborn Partners LLC
✚
|
IL | 20.74 B |
|
Harvest Partners LP
✚
|
NY | 20.25 B |
|
Rokos Capital Management US LP
✚
|
NY | 20.20 B |
|
Audax Management Company LLC
✚
|
MA | 20.12 B |
|
Royalty Pharma Sub-Manager LLC
✚
|
NY | 19.64 B |
|
KPS Capital Partners LP
✚
|
NY | 19.08 B |
|
Great Hill Partners LP
✚
|
MA | 18.99 B |
|
Alpine Management Services III LLC
✚
|
CA | 18.91 B |